Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $92.30 +1.45%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Baxter names John Rogers as CFO, effective October 2026
- Stifel Positive on Viking Holdings (VIK) Earnings: '2027 Booking Curves Continue To Show Strength'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
